Discordance Between the Prognostic Impact of MIPI and Overall Survival in a Multicenter Cohort of Patients with Mantle Cell Lymphoma

Mantle cell lymphoma (MCL) has historically been associated with poor long-term outcomes in many patients (pts). The MCL International Prognostic Index (MIPI) has attempted to improve risk-stratification by dividing patients into three groups based on available clinical and laboratory data. We conducted a multicenter analysis of MCL pts with robust clinical data to characterize the outcomes across risk categories in a heterogeneous population.

Source: Clinical Lymphoma, Myeloma and Leukemia - August 26, 2016 Category: Hematology Authors: Ashley Staton, I. Greenwell, Jeffrey Switchenko, Joseph Maly, Kristie Blum, Steven Parks, Alexey Danilov, Christopher Flowers, Jonathon Cohen Source Type: research